Alvine Pharmaceuticals is conducting a Phase 2a clinical trial for celiac disease ALV003-0921 entitled: "Safety and Efficacy of ALV003 for the Treatment of Celiac Disease" www.clinicaltrials.gov >>
There are variety of organizations devoted to providing celiac disease information, education, screening, diagnosis, treatment, and patient support services.